Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)Application
Figure 2:Western blot analysis using BCL2L2 mAb against human BCL2L2 (AA: 6-118) recombinant protein. (Expected MW is 38.2 kDa)Application
Figure 3:Western blot analysis using BCL2L2 mAb against HEK293 (1) and BCL2L2 (AA: 6-118)-hIgGFc transfected HEK293 (2) cell lysate.Application
Figure 4:Western blot analysis using BCL2L2 mouse mAb against HCT116 (1), LOVO (2), SW480 (3), and HL-60 (4) cell lysate.Application
Figure 5:Immunofluorescence analysis of Hela cells using BCL2L2 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)Application
Figure 6:Flow cytometric analysis of Hela cells using BCL2L2 mouse mAb (green) and negative control (red).Application
Figure 7:Flow cytometric analysis of K562 cells using BCL2L2 mouse mAb (green) and negative control (red).Application
Figure 8:Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using BCL2L2 mouse mAb with DAB staining.Application
Figure 9:Immunohistochemical analysis of paraffin-embedded ovarian cancer tissues using BCL2L2 mouse mAb with DAB staining.| Product Name | BCL2L2 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | BCLW; BCL-W; PPP1R51; BCL2-L-2 |
| Immunogen | Purified recombinant fragment of human BCL2L2 (AA: 6-118) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCICCFCMICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | BCLW BCL-W PPP1R51 BCL2-L-2 |
|---|---|
| Molecular Weight(MW) | 20.7kDa |
| Entrez Gene | 599 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Western blot analysis using BCL2L2 mAb against human BCL2L2 (AA: 6-118) recombinant protein. (Expected MW is 38.2 kDa)
Application
Figure 3:Western blot analysis using BCL2L2 mAb against HEK293 (1) and BCL2L2 (AA: 6-118)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 4:Western blot analysis using BCL2L2 mouse mAb against HCT116 (1), LOVO (2), SW480 (3), and HL-60 (4) cell lysate.
Application
Figure 5:Immunofluorescence analysis of Hela cells using BCL2L2 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)
Application
Figure 6:Flow cytometric analysis of Hela cells using BCL2L2 mouse mAb (green) and negative control (red).
Application
Figure 7:Flow cytometric analysis of K562 cells using BCL2L2 mouse mAb (green) and negative control (red).
Application
Figure 8:Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using BCL2L2 mouse mAb with DAB staining.
Application
Figure 9:Immunohistochemical analysis of paraffin-embedded ovarian cancer tissues using BCL2L2 mouse mAb with DAB staining.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
